Back to search results

Umbilical Cord Wharton's Jelly Injections for Low Back Pain

This study is looking at the safety and feasibility of using umbilical cord Wharton's Jelly allograft injections to treat chronic low back pain. Researchers will give you injections of 10cc's of Wharton's Jelly allograft into your lower back. They want to see if this treatment is safe and if it helps with pain. You might be able to join if you are over 20, have chronic low back pain with a pain score of 4 or more, and your Body Mass Index (BMI) is less than 50. For women, you must be abstinent, surgically sterilized, or postmenopausal. This study plans to enroll 100 participants.

Study design
This is an open-label, non-controlled pilot study, meaning everyone receives the treatment and there is no comparison group. It will involve 100 participants.
What's involved
You will receive a series of lumbar injections. You will also have baseline tests, imaging, and laboratory studies.
Compensation
Not stated in the trial record.
Follow-up
You will be followed for one year after the procedure to evaluate safety, pain relief, and functional improvements.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06361485

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

Recruiting
PHASE1Ages 20+InterventionalTreatment
R3 Stem Cell
~100 participants
Updated 2024-04-11 on ClinicalTrials.gov
What's tested:Lumbar Injections with 10cc's of Wharton's Jelly Allograft

At a glance

Recruiting sites
4 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
C-reactive protein
Measured over Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
+7 more outcomes measured

Conditions

Low Back Pain

Explore related trials

Lower Back PainLumbar arthritisLumbar spondylosisType I Acrocephalosyndactyly

Where it's being run

4 sites across 4 states
Arizona1
California1
New York1
Texas1

Study leadership

  • James Faber, BA · STUDY_CHAIR · Institute of Cellular and Regenerative Medicine IRB

Who to contact

David L Greene, MD, PhD, MBA
[email protected]
(602) 677-8981
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Be over age 20.
Suffering from chronic lumbar pain
Body Mass Index (BMI) \<50 Kilograms/m2.
Pain score of 4 or more on the Numeric Pain Rating Scale (NPRS).
Female participants must be abstinent, surgically sterilized or postmenopausal.
Premenopausal females must be on contraceptive measures and do not anticipate pregnancy during the duration of the study.
Be willing and capable of giving written informed consent to participate in English.
Be willing and capable of complying with study-related requirements, procedures and visits.

Exclusion

Have taken any pain medication including nonsteroidal anti-inflammatory drugs (NSAIDs) within 2 weeks prior to study injection date.
Use anticoagulants have a substance abuse history, and fail to agree not to take any lumbar symptom modifying drugs during the course of the study without discussing and reporting the use to the site Clinical investigator and study team.
Known allergy to penicillin, sulfa or amphotericin medications.
Have had any lumbar injections (at all) of any drug in lumbar spine in the past 6 months.
Have had surgery on the lumbar spine within the past 6 months.
Had a traumatic injury to the lumbar spine with the past 3 months.
Planned elective surgery during the course of the study.
A history of organ or hematologic transplantation, rheumatoid arthritis, or other autoimmune disorders.
Be on immunosuppressive medications.
Have a diagnosis of carcinoma with the past 5 years.
Have a lumbar infection or have used antibiotics for lumbar infection within the past 3 months.
Have participated in any other clinical study or treatment (not just for the lumbar spine, but for any reason) with any investigational product within the past 30 days prior to inclusion of study.
Female participants who are breast feeding or are pregnant or desire to become pregnant during the course of the study.
Contraindications to radiographic or MRI imaging.
Serious neurological, psychological or psychiatric disorders.
Injury or disability claims under current litigation or pending or approved workers compensation claims.

What this trial measures

  • C-reactive proteinBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    C-reactive protein (CRP) is a protein made by the liver. The level of CRP increases when there's inflammation in the body. A simple blood test can check your C-reactive protein level. C-reactive protein is measured in milligrams per liter (mg/L). Results equal to or greater than 8 mg/L or 10 mg/L are considered high. Range values vary depending on the lab doing the test. A high test result is a sign of inflammation. It may be due to serious infection, injury or chronic disease. Your health care provider may recommend other tests to determine the cause.

  • Erythrocyte sedimentation rateBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    Sed rate, or erythrocyte sedimentation rate (ESR), is a blood test that can show inflammatory activity in the body. Because a sed rate test can't pinpoint the problem that's causing inflammation in your body, it's often accompanied by other blood tests, such as the C-reactive protein (CRP) test. ESR is measured in millimeters per hour (mm/hr). The normal values are: 0 to 15 mm/hr in men 0 to 20 mm/hr in women

  • Alanine transaminase (ALT)Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    ALT is an enzyme that converts proteins into energy for the liver cells. Aspartate transaminase (AST). AST is an enzyme that helps the body break down amino acids. Alkaline phosphatase (ALP). ALP is an enzyme important for breaking down proteins. Albumin and total protein. Albumin is a protein made in the liver. Bilirubin. Bilirubin is a substance produced during the breakdown of red blood cells. Gamma-glutamyltransferase (GGT). Higher-than-usual may mean liver damage. L-lactate dehydrogenase (LD). LD is an enzyme found in the liver. Prothrombin time (PT). PT is the time it takes your blood to clot. Standard range: Alanine transaminase (ALT). ALT is an enzyme that converts proteins into energy for the liver cells. Standard range: ALT. 7 to 55 units per liter U/L.

  • Aspartate transaminase (AST)Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    AST is an enzyme that helps the body break down amino acids. . Standard range: AST 8 to 48 units per liter

  • Alkaline phosphatase (ALP)Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    ALP is an enzyme important for breaking down proteins. Standard range: 40 to 129 units per liter

  • AlbuminBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    Albumin is a protein made in the liver. Normal range is 34 to 54 grams/liter.

  • CreatinineBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    Creatinine is a waste product that comes from the digestion of protein in your food and the normal breakdown of muscle tissue. It is removed from the blood through your kidneys. Everyone has some creatinine in their blood, but too much can be a sign of a possible kidney problem. Normal range is 0.6-1.3 milligrams/deciliter

  • Blood Urea Nitrogen (BUN)Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    blood urea nitrogen (BUN) test reveals important information about how well your kidneys are working. A BUN test measures the amount of urea nitrogen that's in your blood. Normal BUN is 6-20 milligrams/deciliter.